Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

BACKGROUND: The optimal anticoagulation strategy for patients with atrial fibrillation (AF) and bioprosthetic valve (BPV) replacement or native valve repair remains uncertain. HYPOTHESIS: We evaluated the safety and efficacy of apixaban vs warfarin in patients with AF and a history of BPV replacemen...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cardiol
Glavni autori: Guimarães, Patricia O., Pokorney, Sean D., Lopes, Renato D., Wojdyla, Daniel M., Gersh, Bernard J., Giczewska, Anna, Carnicelli, Anthony, Lewis, Basil S., Hanna, Michael, Wallentin, Lars, Vinereanu, Dragos, Alexander, John H., Granger, Christopher B.
Format: Artigo
Jezik:Inglês
Izdano: Wiley Periodicals, Inc. 2019
Teme:
Clinical Investigations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522998/
https://ncbi.nlm.nih.gov/pubmed/30907005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23178
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items